With a growing range of new vaccines coming on to the market and evidence that some countries simply could not sustain the significant increases in funding required to maintain immunisation programmes, Gavi's first-ever strategy incorporated a detailed review of how best to deploy its growing resources:

STRATEGIC GOALS

Four strategic goals underpinned Phase II

Strategic Goal 1

Strategic Goal 1

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner

GAVI/2008/Sala Lewis/Tanzania
GAVI/2012/Adrian Brooks/Niger, Nigeria

Strategic Goal 2

Strategic Goal 2

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security

Strategic Goal 3

Strategic Goal 3

Increase the predictability and sustainability of long-term financing for national immunisation programmes

GAVI/2013/Evelyn Hockstein/Congo DRC
GAVI/2014/Duncan Graham-Rowe/Cameroon

Strategic Goal 4 

Strategic Goal 4 

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation

WORKPLAN, ACTIVITIES, OUTPUTS

With a total budget of US$ 297 million available for the strategy's four-year life cycle, any given year in the Gavi strategy contained up to 100 activities. To help measure progress, these activities are reported against 17 outputs.

The 2010 Work Plan Report highlights the 2010 progress under each output. It is based on the reporting provided by WHO, UNICEF, World Bank, AVI TAC and the Gavi Secretariat. The paper includes an annex table summarising the progress per output against the 2010 work plan targets.

Related downloads

Latest news

Lower-income countries investing record amount in immunisation programmes

Against a backdrop of aid cuts, lower-income countries contributed a record US$ 302 million towards Gavi-supported vaccines for 2025.

Nearly 20 million lives saved in Africa through measles vaccinations

Nearly 20 million measles-related deaths have been averted in Africa since 2000 thanks to increasing vaccination coverage, according to the first-ever detailed analysis of immunisation targets on the continent.

Preventive cholera vaccination resumes as global supply reaches critical milestone

First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.

Last updated: 8 Apr 2024